This is particularly important if these inhibitors are shown to affect bone metabolism through independent mechanisms beyond glucose control
While semaglutide and tirzepatide suppress appetite, retatrutide adds direct energy expenditure increases through glucagon-mediated thermogenesis and hepatic fat oxidation
In clinical trials, participants who received Semaglutide injections experienced greater weight loss compared to those who received a placebo
Tryptophan hydroxylase-1 regulates immune tolerance and inflammation
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns